Both in Pharmaceuticals
Syndax Pharmaceuticals vs Jade Biosciences
Over the past year SNDX returned −31.9% and JBIO returned +67.1%; their daily moves had a correlation of 0.23.
SNDX −31.9% JBIO +67.1%Growth of $1, one year, split-adjusted
| Metric | SNDX | JBIO |
|---|---|---|
| Price | $10.45 | $15.04 |
| Market cap | $933.2M | $956.5M |
| Today | −26.87% | +3.23% |
| 1 month | −39.8% | +12.2% |
| 6 months | −49.4% | −40.2% |
| Year to date | −50.3% | −2.5% |
| 1 year | −24.1% | +58.8% |
| Revenue growth (YoY) | +81.6% | — |
| Gross margin | 83.2% | — |
| Net margin | −59.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.2× | — |
| Net cash | $182.3M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 84.0% | 52.6% |
| Short % of float | 21.4% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).